Related references
Note: Only part of the references are listed.Chemokines-What Is Their Role in Colorectal Cancer?
Sara Paczek et al.
CANCER CONTROL (2020)
CXCL-8 in Preoperative Colorectal Cancer Patients: Significance for Diagnosis and Cancer Progression
Sara Paczek et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Comparison between clinical significance of serum CXCL-8 and classical tumor markers in oesophageal cancer (OC) patients
Marta Lukaszewicz-Zajac et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2019)
Potential roles and targeted therapy of the CXCLs/CXCR2 axis in cancer and inflammatory diseases
Yuan Cheng et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2019)
The prognostic value of CXC subfamily ligands in stage I-III patients with colorectal cancer
Xiangde Li et al.
PLOS ONE (2019)
The Crucial Role of CXCL8 and Its Receptors in Colorectal Liver Metastasis
Yaqin Bie et al.
DISEASE MARKERS (2019)
Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors
Prashanth Rawla et al.
GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY (2019)
Chemokine (C-X-C motif) ligand 1 is associated with tumor progression and poor prognosis in patients with colorectal cancer
Changhua Zhuo et al.
BIOSCIENCE REPORTS (2018)
CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer
Sara Cabrero-de las Heras et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Serum chemokine CXCL8 as a better biomarker for diagnosis and prediction of pancreatic cancer than its specific receptor CXCR2, C-reactive protein, and classic tumor markers CA 19-9 and CEA
Ala Litman-Zawadzka et al.
POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ (2018)
Epithelial Hypoxia- Inducible Factor 2α Facilitates the Progression of Colon Tumors through Recruiting Neutrophils
Daniel Triner et al.
MOLECULAR AND CELLULAR BIOLOGY (2017)
Loss of dual-specificity phosphatase-2 promotes angiogenesis and metastasis via up-regulation of interleukin-8 in colon cancer
Shih-Chieh Lin et al.
JOURNAL OF PATHOLOGY (2017)
Circulating Levels of VEGF and CXCL1 Are Predictive of Metastatic Organotropismin in Patients with Colorectal Cancer
Rosa Divella et al.
ANTICANCER RESEARCH (2017)
Tumor angiogenesis and vascular normalization: alternative therapeutic targets
Claire Viallard et al.
ANGIOGENESIS (2017)
CXCL1 Is Critical for Premetastatic Niche Formation and Metastasis in Colorectal Cancer
Dingzhi Wang et al.
CANCER RESEARCH (2017)
The CXCL8-CXCR1/2 pathways in cancer
Qian Liu et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2016)
Curcumin mediates oxaliplatinacquired resistance reversion in colorectal cancer cell lines through modulation of CXC-Chemokine/NF-κB signalling pathway
Vicenc Ruiz de Porras et al.
SCIENTIFIC REPORTS (2016)
Colorectal cancer development and advances in screening
Karen Simon
CLINICAL INTERVENTIONS IN AGING (2016)
The prognostic significance of CXCL1 hypersecretion by human colorectal cancer epithelia and myofibroblasts
Anne-France le Rolle et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity
Jason W. Griffith et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)
CXCR2 inhibition enhances sulindac-mediated suppression of colon cancer development
Yong Suk Lee et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Pathomechanisms: homeostatic chemokines in health, tissue regeneration, and progressive diseases
Hans-Joachim Anders et al.
TRENDS IN MOLECULAR MEDICINE (2014)
The combined use of serum neurotensin and IL-8 as screening markers for colorectal cancer
George Sgourakis et al.
TUMOR BIOLOGY (2014)
Inflammation-related factors predicting prognosis of gastric cancer
Wen-Jun Chang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
The role of CXCR3 and CXCR4 in colorectal cancer metastasis
Teppei Murakami et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
The dual roles of inflammatory cytokines and chemokines in the regulation of autoimmune diseases and their clinical implications
Idit Shachar et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
Multifaceted link between cancer and inflammation
Gautam Sethi et al.
BIOSCIENCE REPORTS (2012)
Interleukin-8 and its receptor CXCR2 in the tumour microenvironment promote colon cancer growth, progression and metastasis
Y. S. Lee et al.
BRITISH JOURNAL OF CANCER (2012)
Down-regulation of CXCL1 inhibits tumor growth in colorectal liver metastasis
Obul R. Bandapalli et al.
CYTOKINE (2012)
CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer
Mikio Kawamura et al.
EUROPEAN JOURNAL OF CANCER (2012)
Overview of the mechanisms regulating chemokine activity and availability
Anneleen Mortier et al.
IMMUNOLOGY LETTERS (2012)
The CXCR2 Antagonist, SCH-527123, Shows Antitumor Activity and Sensitizes Cells to Oxaliplatin in Preclinical Colon Cancer Models
Yan Ning et al.
MOLECULAR CANCER THERAPEUTICS (2012)
The expression and prognostic impact of CXC-chemokines in stage II and III colorectal cancer epithelial and stromal tissue
O. Oladipo et al.
BRITISH JOURNAL OF CANCER (2011)
The expression and role of CXC chemokines in colorectal cancer
Hannelien Verbeke et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2011)
Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models
Yan Ning et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Role of Endothelial Chemokines and Their Receptors during Inflammation
Cecilia L. Speyer et al.
JOURNAL OF INVESTIGATIVE SURGERY (2011)
GROα promotes invasion of colorectal cancer cells
Hideo Ogatai et al.
ONCOLOGY REPORTS (2010)
Emerging roles of chemokines in prostate cancer
David Vindrieux et al.
ENDOCRINE-RELATED CANCER (2009)
Chemokines and Chemokine Receptors: Standing at the Crossroads of Immunobiology and Neurobiology
Richard M. Ransohoff
IMMUNITY (2009)
Identification of GRO1 as a Critical Determinant for Mutant p53 Gain of Function
Wensheng Yan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Differential Activation and Regulation of CXCR1 and CXCR2 by CXCL8 Monomer and Dimer
Mohd W. Nasser et al.
JOURNAL OF IMMUNOLOGY (2009)
ELR plus CXC chemokine expression in benign and malignant colorectal conditions
Claudia Rubie et al.
BMC CANCER (2008)
The role of CXC chemokines and their receptors in cancer
Jo Vandercappellen et al.
CANCER LETTERS (2008)
TSU68 Prevents Liver Metastasis of Colon Cancer Xenografts by Modulating the Premetastatic Niche
Masayoshi Yamamoto et al.
CANCER RESEARCH (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response
Keiichi Koizumi et al.
CANCER SCIENCE (2007)
Correlation of IL-8 with induction, progression and metastatic potential of colorectal cancer
Claudia Rubie et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets
Cinzia Bizzarri et al.
PHARMACOLOGY & THERAPEUTICS (2006)
Clinical significance of serum cytokine measurements in untreated colorectal cancer patients: Soluble tumor necrosis factor receptor type I - An independent prognostic factor
J Kaminska et al.
TUMOR BIOLOGY (2005)
Chemokines in innate and adaptive host defense: Basic chemokinese grammar for immune cells
A Rot et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
The pattern of cytokine gene expression in human colorectal carcinoma
A Csiszar et al.
PATHOLOGY & ONCOLOGY RESEARCH (2004)
Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis
M Darash-Yahana et al.
FASEB JOURNAL (2004)
The epithelial-mesenchymal transition of colon carcinoma involves expression of IL-8 and CXCR-1-mediated chemotaxis
RC Bates et al.
EXPERIMENTAL CELL RESEARCH (2004)
Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2
J Heidemann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Dissemination and growth of cancer cells in metastatic sites
AF Chambers et al.
NATURE REVIEWS CANCER (2002)
Chemokines in cancer
AP Vicari et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2002)
GRO alpha/KC, a chemokine receptor CXCR2 ligand, can be a potent trigger for neuronal ERK1/2 and PI-3 kinase pathways and for tau hyperphosphorylation - a role in Alzheimer's disease?
MQ Xia et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Chemokines: A new classification system and their role in immunity
A Zlotnik et al.
IMMUNITY (2000)
Share Paper
